A new synthesis of decades of research has created a working model that links specific members of the CHD protein family to discrete stages of cardiac development, offering a unifying framework for understanding the origins of congenital heart defects. The review, published in the World Journal of Pediatrics (DOI: 10.1007/s12519-026-01049-y), systematically evaluates evidence from human genetics, animal models, and stem-cell systems to assign distinct roles to CHD proteins in heart formation.
CHD proteins physically reshape DNA to control gene activity, and the review reveals a clear division of labor among them. CHD7, the gene most frequently mutated in CHARGE syndrome, shows the strongest link to cardiac development, playing a dominant role in building the heart's early structure. CHD3 and CHD4 act as "identity guardians," ensuring that heart cells commit to the correct fate during chamber formation. CHD8 appears to regulate later ventricular growth and functional maturation. The authors propose three testable models—parallel, sequential, and compensatory—for how these remodelers might coordinate across developmental time.
The findings have direct implications for clinical practice. For genetic screening, the study provides clear priorities: CHD7 for outflow-tract defects, CHD4 for chamber-patterning anomalies, and CHD8 for ventricular dysfunction. This prioritization can improve diagnostic efficiency. Therapeutically, while directly targeting remodelers is risky due to their broad expression, identifying their downstream pathways may offer safer drug targets. Future studies combining time-resolved multi-omics and combinatorial genetics could uncover how these proteins coordinate, potentially paving the way for precise epigenetic therapies.
